{
  "main_header": {
    "sid": 201791,
    "name": "Biocon",
    "stock_name": "Biocon",
    "full_name": "Biocon Ltd.",
    "name_url": "stocks-analysis/biocon",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "411.05",
    "chg": -0.65,
    "chgp": "-0.16%",
    "dir": -1,
    "prev_price": "411.70",
    "mcapval": "66,627.41 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532523,
    "symbol": "BIOCON",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE376G01013",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "8.72 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/biocon-201791-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "\\'We\\'ll become top insulin supplier\\': Biocon\\'s new target as Big Pharma shifts to GLP-1 drugs",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-17 15:30:05",
        "description": "\\'We\\'ll become top insulin supplier\\': Biocon\\'s new target as Big Pharma shifts to GLP-1 drugs  Business Today..."
      },
      {
        "title": "Biocon aims to become worlds top insulin supplier in five years",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-16 13:58:40",
        "description": "Biocon aims to become worlds top insulin supplier in five years  BusinessLine..."
      },
      {
        "title": "Watch Biocon\\'s Mazumdar-Shaw Says Firm On Track To Be Top Insulin Maker",
        "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxONk53S1F1NHk3U2VPQ25mdkpGX0Ryc0o2UEZEeHUtcHdMSERhNV96SGZWSUx4eUlXUlJWTlV0MU9GdVFMbWIydmRwVWdqcjYxS05GTm55ckNsZ0VFVEx5WTBfdjM4cl9aRXVTSUs1RTQzam9HWVFObmpDbm9zbENTT3ljTWFvTG5rSENFQlowT1QwS0hiRG0yQzFGb2wxNUVMSTNqT0Z4TQ?oc=5",
        "imagepath": "",
        "date": "2026-06-16 08:13:04",
        "description": "Watch Biocon\\'s Mazumdar-Shaw Says Firm On Track To Be Top Insulin Maker  Bloomberg..."
      },
      {
        "title": "Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-21 12:24:36",
        "description": "Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?  Mint..."
      }
    ],
    "total": 4,
    "sid": "201791",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/biocon-201791"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "10-Jun-2026",
      "details": "Acquisition",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "08-Jun-2026",
      "details": "Postal Ballot - Outcome",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "08-Jun-2026",
      "details": "Postal Ballot - Scrutinizers Report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has declared <strong>10%</strong> dividend, ex-date: 03 Jul 26",
          "dt": "2026-07-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 12 Jun 19",
          "dt": "2019-06-12",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

\'We\'ll become top insulin supplier\': Biocon\'s new target as Big Pharma shifts to GLP-1 drugs

2026-06-17 15:30:05

\'We\'ll become top insulin supplier\': Biocon\'s new target as Big Pharma shifts to GLP-1 drugs Business Today...

Read More

Biocon aims to become worlds top insulin supplier in five years

2026-06-16 13:58:40

Biocon aims to become worlds top insulin supplier in five years BusinessLine...

Read More

Watch Biocon\'s Mazumdar-Shaw Says Firm On Track To Be Top Insulin Maker

2026-06-16 08:13:04

Watch Biocon\'s Mazumdar-Shaw Says Firm On Track To Be Top Insulin Maker Bloomberg...

Read More

Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?

2026-05-21 12:24:36

Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks? Mint...

Read More

View All News